Beverly Sha to Female
This is a "connection" page, showing publications Beverly Sha has written about Female.
Connection Strength
0.595
-
Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection. J Emerg Med. 2019 11; 57(5):732-739.
Score: 0.053
-
Enhanced inpatient rounds, appointment reminders, and patient education improved HIV care engagement following hospital discharge. Int J STD AIDS. 2018 06; 29(7):641-649.
Score: 0.047
-
Burkholderia pseudomallei Infection in US Traveler Returning from Mexico, 2014. Emerg Infect Dis. 2015 Oct; 21(10):1884-5.
Score: 0.040
-
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23.
Score: 0.029
-
Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol. 2008 Jun; 78(1):76-9.
Score: 0.024
-
Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis. 2007 Oct; 11(4):240-50.
Score: 0.023
-
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol. 2005 Sep; 43(9):4607-12.
Score: 0.020
-
Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005 Jan 01; 191(1):25-32.
Score: 0.019
-
Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy. Nutrition. 2004 Nov-Dec; 20(11-12):1022-5.
Score: 0.019
-
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 2004 May 21; 18(8):1203-6.
Score: 0.018
-
Development of a predictive model for identifying women vulnerable to HIV in Chicago. BMC Womens Health. 2023 Jun 16; 23(1):313.
Score: 0.017
-
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e613-e621.
Score: 0.017
-
A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS. Nutrition. 2002 Jul-Aug; 18(7-8):688-90.
Score: 0.016
-
Effectiveness of an electronic health record model for HIV pre-exposure prophylaxis. Int J STD AIDS. 2022 04; 33(5):499-502.
Score: 0.016
-
Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 2000 Dec 06; 284(21):2723.
Score: 0.014
-
Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status. J Immunol. 2020 10 15; 205(8):2046-2055.
Score: 0.014
-
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy. AIDS. 2000 Jul 07; 14(10):1470-1.
Score: 0.014
-
Implementing Rapid Initiation of Antiretroviral Therapy for Acute HIV Infection Within a Routine Testing and Linkage to Care Program in Chicago. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220939754.
Score: 0.014
-
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380.
Score: 0.013
-
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. Clin Infect Dis. 2018 05 17; 66(11):1689-1697.
Score: 0.012
-
Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments. Ann Emerg Med. 2018 07; 72(1):29-40.e2.
Score: 0.012
-
Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. AIDS. 2017 11 28; 31(18):2483-2492.
Score: 0.012
-
Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8.
Score: 0.012
-
Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. AIDS Care. 2016 10; 28(10):1274-9.
Score: 0.010
-
HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):486-95.
Score: 0.010
-
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. J Acquir Immune Defic Syndr (1988). 1992 Oct; 5(10):1051-8.
Score: 0.008
-
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis. 1991 Nov; 164(5):973-5.
Score: 0.008
-
Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5.
Score: 0.007
-
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100.
Score: 0.006
-
Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis. 2006 Sep; 8(3):171-6.
Score: 0.005
-
Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus load. AIDS Res Hum Retroviruses. 2005 Nov; 21(11):945-8.
Score: 0.005
-
Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis. 2005 Jun 01; 191(11):1913-21.
Score: 0.005
-
Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005 Apr 01; 191(7):1129-39.
Score: 0.005
-
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
Score: 0.004
-
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
Score: 0.004
-
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33.
Score: 0.004
-
Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. J Infect Dis. 2002 Feb 15; 185(4):439-47.
Score: 0.004
-
Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS. 2001 Mar 09; 15(4):441-9.
Score: 0.004
-
Body composition in HIV-infected women. Nutrition. 2000 Nov-Dec; 16(11-12):1064-8.
Score: 0.004
-
Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS. 1999 Oct 01; 13(14):1905-12.
Score: 0.003
-
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
Score: 0.003
-
Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999 Jul 01; 21(3):194-202.
Score: 0.003
-
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25.
Score: 0.003
-
A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis. 1998 Nov; 178(5):1343-51.
Score: 0.003
-
Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov; 25(10):527-32.
Score: 0.003
-
Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):454-9.
Score: 0.003
-
A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26.
Score: 0.003